Similar articles

• Celiprolol: a haemodynamic appraisal in comparison with propranolol.

  Solomon T, Gensini G, Dator C, Caruso F. Solomon T, et al. Br J Clin Pract Suppl. 1985 Jun;40:43-4. Br J Clin Pract Suppl. 1985. PMID: 2864062 No abstract available.
• Effects of celiprolol, a cardioselective beta-blocker, on respiratory function in asthmatic patients.

  Pujet JC, Dubreuil C, Fleury B, Provendier O, Abella ML. Pujet JC, et al. Eur Respir J. 1992 Feb;5(2):196-200. Eur Respir J. 1992. PMID: 1348481 Clinical Trial.
• The bronchosparing effect of celiprolol, a new beta 1- alpha 2-receptor antagonist on pulmonary function of propranolol-sensitive asthmatics.

  Matthys H, Doshan HD, Rühle KH, Braig H, Pohl M, Applin WJ, Caruso FS, Neiss ES. Matthys H, et al. J Clin Pharmacol. 1985 Jul-Aug;25(5):354-9. doi: 10.1002/j.1552-4604.1985.tb02854.x. J Clin Pharmacol. 1985. PMID: 2863289 Clinical Trial.
• Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.

  Pruss TP, Khandwala A, Wolf PS, Grebow P, Wong L. Pruss TP, et al. J Cardiovasc Pharmacol. 1986;8 Suppl 4:S29-32. J Cardiovasc Pharmacol. 1986. PMID: 2427849 Review.
• Celiprolol: its profile as a potential antiarrhythmic agent.

  Pruss TP. Pruss TP. Am Heart J. 1988 Nov;116(5 Pt 2):1412-5. doi: 10.1016/0002-8703(88)90132-9. Am Heart J. 1988. PMID: 2461069 Review.